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with the incidence of membrane resistance (B: -8.7, CI: -16.4 - -1.0,
p¼0.027). There were no significant influences of other investigated
maternal lifestyle factors on oocyte dimorphisms.
CONCLUSIONS: Cigarette smoking and the consumption of refined
sugar appear to reduce oocyte quality. Therefore, it would be wise to advise
female partners undergoing assisted reproduction treatments to abstain from
smoking and consuming sugar to avoid decreased in vitro reproduction
outcomes.
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OBJECTIVE: To assess the association between infertility and environ-
mental, chemical, or hazardous material exposures among United States Vet-
erans.
DESIGN: Cross-sectional survey study.
MATERIALS AND METHODS: A national sample of female and male
US Veterans aged 20-45 completed a computer-assisted telephone interview
lasting an average of 1 hour 27 minutes assessing demographics, general and
reproductive health, and lifetime and military exposures.
Infertility was defined as unprotected intercourse with a member of the
opposite sex, with or without trying to conceive, for >12 months without
pregnancy over a lifetime. Participants reporting never having had unpro-
tected intercourse were excluded from analysis.
Logistic regression analysis was used to compare exposures among infer-
tile and non-infertile groups. Odds ratios (OR) with 95% confidence intervals
are reported.
RESULTS: 3,018 Veterans participated in this study. After excluding par-
ticipants never reporting unprotected intercourse (216 women and 201 men),
1,194 women and 1,407 men were included in this analysis with 592 (50%)
women and 727 (52%) men meeting the definition of infertility.
Exposures reported to be higher among both women and men meeting
the definition of infertility than among those not meeting this definition
included polychlorinated biphenyl (PCBs) (4.7% vs. 2.3% exposed in
the infertile and non-infertile groups respectively; OR 2.09 (1.09-4.00)
for women; 9.5% vs 6.2%; OR 1.59 (1.07-2.37) for men) and sulfur fires
(2.2% vs. 0.5%; OR 4.48 (1.27-15.81) for women; 4.0% vs 2.1%; OR 1.98
(1.04-3.77) for men).
Exposures reported to be higher only amongwomenmeeting the definition
of infertility than among women not meeting this definition were extreme
heat (66.3% vs 59.0%; OR 1.37 (1.08-1.74)), chemical weapons (e.g., Sarin
gas) (10.7% vs 6.8%; OR 1.63 (1.08-2.46)) and anthrax vaccine (54.2% vs.
45.9%; OR 1.40 (1.11-1.75)).
Exposures reported to be higher only among men meeting the definition of
infertility than among men not meeting this definition included exposure to
oil well fires (16.8% vs. 11.5%; OR 1.56 (1.15-2.11)), petrochemicals
(71.4% vs 64.9%; OR 1.35 (1.08-1.69)), other chemicals (such as solvents,
degreasers) (55.3% vs. 49.4%; OR 1.27 (1.03-1.56)), and asbestos (35.4%
vs. 28.2%; OR 1.39 (1.11-1.74)).
There were no queried exposures self-reported at higher rates in the non-
infertile group.
CONCLUSIONS: During their military service, Veterans commonly
experience exposure to chemical, physical, and environmental hazards
that may have negative effects on their future reproductive health. Our
study found that Veterans reporting at least one episode of 12 months or
more of unprotected intercourse without conception over their lifetime
were more likely to report exposure to such hazards, especially PCBs
and sulfur fires. These data provide evidence of an association between ex-
posures encountered during military service and infertility, and thereby
support recent efforts to improve coverage of fertility preservation and
fertility treatment for Veterans.
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OBJECTIVE: To describe our single-center experience and results of uni-
versal SARS-CoV-2 testing in asymptomatic patients undergoing controlled
ovarian hyperstimulation (COH).
DESIGN: Retrospective cohort study conducted at a university-affiliated
center.
MATERIALS AND METHODS: On March 21, 2020, New York-Presby-
terian Hospital, where our retrieval suite is located, instituted a policy of uni-
versal SARS-CoV-2 testing prior to surgical procedures requiring anesthesia.
As a result, we began testing all patients undergoing COH for SARS-CoV-2
using reverse transcription-polymerase chain reaction via nasopharyngeal
swabs (Roche Cobas 6800). Tests were performed on the morning of cycle
start and repeated 24 hours before oocyte retrieval. A positive test at either
time point excluded patients from continuing with treatment. During the
testing period, all patients and staff were required to wear surgical masks
at all times when at our center and consented to symptom and temperature
screening at every monitoring visit.
RESULTS: Between March 21 and May 20, 2020, 169 asymptomatic pa-
tients underwent nasopharyngeal swabs at cycle start, four of which returned
positive for SARS-CoV-2 for a center prevalence of 2.4%. All four patients
were asymptomatic at the time of cycle start and were not permitted to begin
their COH cycle. One of these patients had previously had a positive PCR
swab over 60 days prior and had been symptom-free during this interval.
One patient with a negative PCR swab on cycle start subsequently converted
to positive 15 days later on her PCR swab prior to retrieval, despite the
absence of COVID-19 symptoms. Per our hospital policy, she was not al-
lowed to proceed with oocyte retrieval and was started on a course of daily
GnRH antagonist and asked to abstain from intercourse for 14 days. None
of the 5 patients went on to develop COVID-19 symptoms following their
positive test result. All patients were referred to follow-up with their primary
care provider. Prior to returning for further COH treatment, all patients will
be required to undergo repeat PCR testing with a negative result.
CONCLUSIONS: While rare, asymptomatic carriers of the SARS-CoV-2
virus were identified for a center prevalence of 2.4% in patients undergoing
COH. Despite initial negative PCR testing, patients may convert to positive
over the course of a COH cycle and not demonstrate symptoms. Strict per-
sonal protective equipment and social distancing use is essential to protect
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OBJECTIVE: To evaluate the effect of exposure to pollution (fine inhal-
able particulate matter - PM2.5) from the city of S~ao Paulo on sperm func-
tional quality.
DESIGN: Male isogenic BALB/c mice were used, distributed in two
groups, control (n¼6) and polluted air (n¼8). For the polluted air group, after
weaning (21 days), animals were daily exposed to 600 mg/m3 of PM2,5 for 96
days in an Ambient Particle Concentrator (APC). Control group was simul-
taneously exposed to filtered air in the APC. On postnatal day 118, animals
were sacrificed (isoflurane overdose), body was weighted and the epididymis
were collected.
MATERIALS AND METHODS: Sperm obtained from the cauda epidid-
ymis were used for the evaluation of motility, mitochondrial activity (DAB
staining), acrosome integrity (PNA staining), DNA fragmentation (alkaline
comet assay), oxidative stress (DHE staining) and cell viability (PI staining).
Groups were compared using an unpaired Student’s t test (p<0.05).e17
RESULTS: Groups did not differ regarding body weight, and sperm
motility. Furthermore, air pollution did not alter sperm functional quality
(Table 1).
CONCLUSIONS: Exposure to high concentrations of PM2.5 does not
affect sperm motility and functional parameters.
TABLE 1. Body weight and sperm functional quality of mice from the control
and polluted air groups. Data are presented as Mean  Standard Deviation.
Groups were compared using an unpaired Student’s t test.
Control Polluted aire18 ASRM Abstracts(n¼6) (n¼8) pBody weight 29.46  4.82 28.01  0.82 0.50
Motility (%) 51.67  13.66 55.62  18.41 0.67
Intact acrosome (%) 85.33  7.65 81.94  9.08 0.48
Mitochondrial activityDAB I (%) 7.08  4.53 9.81  10.19 0.56
DAB II (%) 71.75  11.16 68.44  61.75 0.53
DAB III (%) 20.83  9.31 21.06  11.55 0.97
DAB IV (%) 0.33  0.61 0.75  0.96 0.37DNA fragmentation
Comet I (%) 29.83  23.17 35.07  23.16 0.69
Comet II (%) 45.83  10.81 36.36  12.90 0.18
Comet III (%) 17.92  10.88 16.36  9.70 0.79
Comet IV (%) 6.58  9.11 12.14  11.70 0.37
Tail DNA (%) 14.11  12.67 19.82  15.38 0.49
Olive Tail Moment (a.u.) 5.41  5.91 7.27  6.60 0.61
Comet Distribute
Moment (a.u.)50.32  43.00 35.80  4.59 0.48Oxidative stress
DHE positive (%) 21.98  19.71 12.63  11.22 0.28Cell viability
PI positive (%) 51.47  14.33 47.70  13.74 0.63DAB (3,3’-diaminobenzidine); DAB I: 100% ofmitochondrias stained; DAB
II: >50% mitochondrias stained, DAB III: <50% mitochondias unstained,
DAB IV: no mitochondrias stained. Comet I: no DNA fragmentation; Comet
II: low DNA fragmentation; Comet III: increased DNA fragmentation;
Comet IV: high DNA fragmentation. a.u: arbitrary units. DHE (Dihydroethi-
dium) positive: presence of superoxide anion stained with DHE. PI (Propi-
dium Iodide) positive: permeable sperm membranes.
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OBJECTIVE: Current ACOG carrier screening guidelines do not support
routine inclusion of X-linked (XL) conditions. There are over 100 known XL
conditions. Clinical presentation depends on many variables and males are
typically affected while females may show varying symptoms. Despite
high de novo mutation rates, the identification of carriers for XL conditions
is important as females have a 50% chance of transmitting a disease-causing
variant. The aim of this study was to determine the carrier frequency of XL
conditions identified through routine carrier screening for the purpose of
reproductive planning.
DESIGN: Retrospective cohort study of patients undergoing routine car-
rier screening to determine carrier rates of a subset of XL conditions.
MATERIALS AND METHODS: Carrier screening was performed by
next-generation sequencing with full coding sequence and deletion and
duplication analysis for up to 301 genes as ordered on 68,100 patients.
Twenty-two of the 301 genes were XL. Pathogenic and likely pathogenic var-
iants were reported. Ordering patterns and positive rates for XL conditions
were assessed.
RESULTS: Of 68,100 patients, 68% were female and 32% were male.
Most orders (87.9%; 59,865) included at least one XL condition, thoughfemale orders included XL conditions more often than male orders (91.9%
vs 79.4%).
Of the 59,865 orders that include XL conditions, the overall positive rate
was 60.9% and of these positives, 1.98% were for XL conditions, giving an
overall positive rate for XL conditions of 1.2%. In this dataset, at least one
carrier was identified for each of the 22 XL conditions tested.
When stratified by patient sex, 1.3% of females (557/42,572) tested posi-
tive for an XL condition, most frequentlyG6PD,FMR1,DMD,COL4A5, and
ABCD1; 0.95% of males (165/17,293) were positive for an XL condition,
most frequently G6PD, FMR1, COL4A5, DMD, and GLA.
CONCLUSIONS: In this cohort, 88% of all orders included at least one
XL condition, indicating that clinicians are regularly ordering XL condi-
tions as part of their routine carrier screening for both male and female
patients. One point two percent of individuals were positive for at least
one XL condition, and XL conditions together accounted for 2% of all
positive results.
The inclusion of XL conditions on a carrier screen is controversial: ACOG
does not support it; the line between carrier screening and diagnostic testing
may be crossed for male patients who screen positive for variants in XL con-
ditions; and the high de novo rate in many of XL conditions may lead to false
reassurance after a negative carrier screening result.
However, inclusion of XL conditions in routine carrier screening is com-
mon practice. Screening for XL conditions allows patients the opportunity to
make informed reproductive decisions about these often severe conditions
with high reproductive risks. Additional studies are needed to determine
the phenotypes and potential impact associated with males identified with
XL conditions in this study.
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OBJECTIVE: Preimplantation genetic testing for aneuploidy (PGT-A) has
been shown to improve the likelihood of live birth per embryo transfer. How-
ever, oocyte aneuploidy is significantly associated with reproductive aging,
and the probability of an IVF cycle resulting in a lack of euploid embryos be-
comes more significant for women of advanced maternal age (>38 years).
The aim of this study was to review patient’s treatment decisions following
an all aneuploid PGT-A cycle to assist in future clinical management and
counseling practices.
DESIGN: Retrospective cohort analysis.
MATERIALS AND METHODS: Consecutive, autologous PGT-A cycles
that resulted in all aneuploid blastocysts between January 2016 and
December 2019 (n¼550) were included in this analysis. Individual variable
analysis was performed using Wilcoxon rank sum test. Step-wise logistic
regression models evaluated whether 12 clinical parameters were predictive
of patient treatment decisions including parental ages, prior live birth, BMI,
ovarian reserve variables and IVF cycle characteristics. Significance deter-
mined at p<0.05.
RESULTS: Nearly half of the couples (47.6%) decided to terminate treat-
ment following an all aneuploid IVF cycle. Only a small number of couples
pursued donor oocytes for future treatment (7.6%) and a handful naturally
conceived (1.5%). The remaining couples (43.3%) pursued a second autolo-
gous PGT-A cycle, with 50.4% obtaining R1 euploid blastocyst. Interest-
ingly, women who chose to stop treatment had significantly more oocytes
retrieved (p<0.05) but trended towards being less likely to have had prior
live births (p¼ 0.07) than women who continued infertility treatment. Other
variables, including maternal age, AMH and resting antral follicle count
(AFC), were not significantly different. Women with euploid blastocysts
following their second IVF cycle were significantly younger (p<0.001, OR
¼ 0.84) and had higher AMH (p<0.05, OR ¼ 1.25) than women with a
consecutive second all aneuploid cycle. Stratification of subsequent euploid
frozen blastocyst transfers demonstrated the trend of lower maternal age (p¼
0.06, OR¼0.89), higher AFC (p<0.05, OR ¼ 1.06) and more mature autol-
ogous oocytes (p<0.05, OR¼ 1.12) in association with a positive pregnancy
outcome.Vol. 114, No. 3, Supplement, September 2020
